The IBN SINA Pharmaceutical Industry PLC's latest marketcap:
As of 07/05/2025, The IBN SINA Pharmaceutical Industry PLC's market capitalization has reached $73.26 M. According to our data, The IBN SINA Pharmaceutical Industry PLC is the 26905th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 73.26 M |
| Revenue (ttm) | 95.8 M |
| Net Income (ttm) | 5.14 M |
| Shares Out | 31.24 M |
| EPS (ttm) | 0.16 |
| Forward PE | 12.51 |
| Ex-Dividend Date | 10/28/2024 |
| Earnings Date | 08/28/2025 |
The IBN SINA Pharmaceutical Industry PLC's yearly market capitalization.
| Date | Market Cap(BDT) | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | 73.26 M | 0.73% | 26905 |
| 12/30/2024 | 8.96 B | 0.07% | 25270 |
| 12/28/2023 | 8.95 B | 0% | 24447 |
| 12/29/2022 | 8.95 B | 5.64% | 23213 |
| 12/30/2021 | 8.48 B | 11.19% | 23145 |
| 12/30/2020 | 7.62 B | 9.71% | 21242 |
| 12/30/2019 | 6.95 B | -11.61% | 19201 |
| 12/27/2018 | 7.86 B | 13.24% | 17573 |
| 12/28/2017 | 6.94 B | 35.44% | 18895 |
| 12/29/2016 | 5.13 B | 52.59% | 18092 |
Company Profile
About IBN SINA Pharmaceutical Industry PLC
IBN SINA Pharmaceutical Industry PLC is a leading pharmaceutical company based in Bangladesh, operating both domestically and internationally. Established in 1983 and headquartered in Dhaka, the company specializes in the production and sale of a diverse range of pharmaceutical products.
Product Portfolio
The company offers a comprehensive selection of pharmaceutical drugs in various forms, including:
- Solid Dosage Forms: Tablets and capsules
- Parenteral Products: Ampoules and vials
- Liquid Dosage Forms: Syrups, solutions, suspensions, and powder for suspension (dry syrups)
- Sterile Ophthalmic Products: Eye drops, creams, ointments, gels, and sachets
Therapeutic Categories
IBN SINA provides a wide array of therapeutic products, covering:
- Analgesic & Anti-inflammatory
- Anti-allergic & Ocular
- Anti-diabetic & Cardiovascular
- Antibacterial & Antiviral
- Gastrointestinal & Anti-ulcerant
- Hormonal & Multivitamin supplements
- Neurological & Psychiatric agents
- Urological & Respiratory preparations
Additional Offerings
Beyond conventional pharmaceuticals, the company also specializes in:
- Herbal and Unani products
- Active Pharmaceutical Ingredients (APIs)
- Natural medicines
- Packaging solutions (plastic bottles, tubes, laminated tubes)
Frequently Asked Questions
-
What is The IBN SINA Pharmaceutical Industry PLC's (DSE-IBNSINA) current market cap?As of 07/05/2025, The IBN SINA Pharmaceutical Industry PLC (including the parent company, if applicable) has an estimated market capitalization of $73.26 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does The IBN SINA Pharmaceutical Industry PLC (DSE-IBNSINA) rank globally by market cap?The IBN SINA Pharmaceutical Industry PLC global market capitalization ranking is approximately 26905 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.